DAX21.260 +1,5%ESt504.972 +1,2%Top 10 Crypto11,25 -1,6%Dow40.566 +0,1%Nas16.857 +0,2%Bitcoin75.423 +1,2%Euro1,1305 -0,4%Öl64,56 -0,4%Gold3.224 +0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Apple 865985 Tesla A1CX3T Lufthansa 823212 Mercedes-Benz Group (ex Daimler) 710000 Amazon 906866 Infineon 623100 HENSOLDT HAG000 BASF BASF11 Allianz 840400 Deutsche Bank 514000 BYD A0M4W9 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX über 21.000er-Marke -- Wall Street in Grün -- Rheinmetall-Aktie markiert neues Allzeithoch -- Apple wieder über 3-Billionen-Marke -- LVMH, NVIDIA, BoA, Dägerwerk, Citi im Fokus
Top News
Bitcoin, Ethereum, Litecoin & Co.: Wie sich die Kryptokurse am Nachmittag entwickeln Bitcoin, Ethereum, Litecoin & Co.: Wie sich die Kryptokurse am Nachmittag entwickeln
Biogen-Aktie dennoch in Rot: Biogen und Eisai erhalten EU-Zulassung für Alzheimer-Wirkstoff Biogen-Aktie dennoch in Rot: Biogen und Eisai erhalten EU-Zulassung für Alzheimer-Wirkstoff
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Doppel-Chance bei ZERO: 1 Aktie geschenkt für Neukunden + Zusatz-Chance auf eine New York-Reise - Jetzt informieren!

Illumina Aktie

NeuKaufenVerkaufen
Illumina Aktien-Sparplan
66,19 EUR -0,12 EUR -0,18 %
HAN
75,01 USD -0,04 USD -0,05 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.10,47 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN927079

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4523271090

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolILMN

Illumina Aktien News

DatumMeistgelesen
PR NewswireIllumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries
PR NewswireIllumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors
PR NewswireIllumina responds to European Commission's divestiture order
PR NewswireIllumina Posted a Stewardship-Focused Presentation for Investors
PR NewswireIllumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023
PR NewswireIllumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireIllumina expands genomics capabilities in India with opening of Solutions Center
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireDr. Steven Barnard Appointed Chief Technology Officer
PR NewswireIllumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
PR NewswireIllumina to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
PR NewswireThe Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck
PR NewswireIllumina DRAGEN™ 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery
PR NewswireIllumina announces CEO transition plan
PR NewswireIllumina releases 2022 Corporate Social Responsibility Report
PR NewswireIllumina's Board of Directors elects two experienced Independent Directors to Board
PR NewswireIllumina unveils AI software to predict disease-causing genetic mutations in patients
PR NewswireIllumina to Host Third Annual Virtual ESG Investor Event on Monday, June 12, 2023
PR NewswireReal-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing
PR NewswireIllumina announces preliminary results of annual meeting
PR NewswirePluton Biosciences Raises $16.5M Series A led by Illumina Ventures and RA Capital to discover and deploy microbes that will fight climate change
PR NewswireIllumina Board Chair issues letter to shareholders and urges shareholders to vote the WHITE proxy card FOR all nine of Illumina's nominees
PR NewswireIllumina's genomic technologies enable better pathogen preparedness and response
PR NewswireIllumina sends letter to shareholders detailing why Illumina's nominees far outmatch Icahn's slate in skills and experience
PR NewswireLeading Proxy Advisory Firm ISS Recommends Illumina Shareholders Vote "FOR" Eight of Illumina's Highly Qualified Director Nominees
PR NewswireIllumina Sends Letter to Shareholders Highlighting Board Strength, Weakness of Icahn's "Plan"
PR NewswireIllumina Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card
PR NewswireIllumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth
PR Newswire2,800 Singapore Students to Benefit from new STEM Partnership
PR NewswireIllumina Urges Shareholders to Vote the WHITE Proxy Card FOR all Nine of Illumina's Nominees
PR NewswireIllumina Singapore continues to climb in Best Employers Award Reaching 7th Overall
PR NewswireIllumina's cloud-based informatics programs recognized for robust, international data privacy protections
PR NewswireIllumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients
PR NewswireIllumina celebrates 25 years of innovation
PR NewswireIllumina to Announce First Quarter 2023 Financial Results on Tuesday, April 25, 2023
PR NewswireIllumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023
PR NewswireIllumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024
PR NewswireIllumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee
PR NewswireIllumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease
Wer­bung

Illumina News

Illumina News: auf dieser Seite finden Sie alle Illumina News und Nachrichten zur Illumina Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Illumina News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Illumina News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.